Outcomes Following Exenteration for Gynecological Neoplasms
Päivi Kannisto
Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden
Search for more papers by this authorFredrik Liedberg
Institution of Translational Medicine, Lund University, Malmö, Sweden
Department of Urology, Skåne University Hospital, Malmö, Sweden
Search for more papers by this authorMarie-Louise Lydrup
Division of Surgery, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden
Search for more papers by this authorPäivi Kannisto
Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden
Search for more papers by this authorFredrik Liedberg
Institution of Translational Medicine, Lund University, Malmö, Sweden
Department of Urology, Skåne University Hospital, Malmö, Sweden
Search for more papers by this authorMarie-Louise Lydrup
Division of Surgery, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden
Search for more papers by this authorMichael E. Kelly
St. Vincent's University Hospital, Dublin, Ireland
Search for more papers by this authorDesmond C. Winter
St. Vincent's University Hospital, Dublin, Ireland
Search for more papers by this authorSummary
The primary treatment of gynecological malignancies has considerably evolved over the last century, with a move to less aggressive procedures when appropriate. However, gynecological malignancies comprise a heterogeneous group, with varying treatment options. The choice of reconstructive method for urinary and fecal diversion is crucial, as most patients have been irradiated with high doses or had prior surgery for their primary neoplasm. Patient characteristics, such as age and comorbidity, also affect the choice of urinary diversion, especially when opting for a continent reconstruction in the setting of an anterior exenteration for a gynecological cancer. For patients with advanced gynecological tumors requiring both urinary and fecal diversion, that is, two stomas, a double-barreled colostomy has been popularized. The optimal localization of the urinary stoma is an integral part of the preoperative preparation and of critical importance to avoid postoperative difficulties with stoma accessories or emptying a continent cutaneous diversion.
References
- Brunschwig , A. ( 1948 ). The surgical treatment of cancer of the cervix uteri; a radical operation for cancer of the cervix . Bull. N. Y. Acad. Med. 24 : 672 – 683 .
- Kaur , M. , Joniau , S. , D'Hoore , A. et al. ( 2012 ). Pelvic exenterations for gynecological malignancies. A study of 36 cases . Int. J. Gynecol. Cancer 22 : 889 – 896 .
- Jäger , L. , Nilsson , P. , and Flöter Rådestad , A. ( 2013 ). Pelvic exenteration for recurrent gynecologic malignancy. A study of 28 consecutive patients at a single institution . Int. J. Gynecol. Cancer 23 : 755 – 762 .
- Kinney , W. , Alvarez , R. , Reid , G. et al. ( 1989 ). Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study . Gynecol. Oncol. 34 : 258 – 262 .
- Rotman , M. , Sedlis , A. , Piedmonte , M. et al. ( 2006 ). A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study . Int. J. Radiat. Oncol. Biol. Phys. 65 ( 1 ): 169 – 176 .
- Gupta , S. , Maheshwari , A. , Parab , P. et al. ( 2018 ). Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial . J. Clin. Oncol. 12 : JCO2017759985.
- Shah , C. , Goff , B. , Lowe , K. et al. ( 2009 ). Factors affecting risk of mortality in women with vaginal cancer . Obstet. Gynecol. 113 : 1038 – 1045 .
- Nout , R. , Smit , V. , Putter , H. et al. ( 2010 ). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial . Lancet 375 : 816 – 823 .
- Creutzberg , C. , Nout , R. , Lybeert , M. et al. ( 2011 ). Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial cancer . Int. J. Radiat. Oncol. Biol. Phys. 81 : e631 – e638 .
- Forner , M. and Lampe , B. ( 2012 ). Exenteration in the treatment of stage III/IV vulvar cancer . Gynecol. Oncol. 124 : 87 – 91 .
- Di Donato , V. , Bracchi , C. , Cigna , E. et al. ( 2017 ). Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques . Surg. Oncol. 26 : 511 – 521 .
- Andikyan , V. , Khoury-Collado , F. , Sonoda , Y. et al. ( 2012 ). Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery . Gynecol. Oncol. 125 : 404 – 408 .
- Schmidt , A. , Imesch , P. , Fink , D. , and Egger , H. ( 2016 ). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients . Int. J. Gynecol. Cancer 26 : 716 – 721 .
- Höckel , M. and Dornhöfer , N. ( 2006 ). Pelvic exenteration for gynaecological tumours: achievements and unanswered questions . Lancet Oncol. 7 : 837 – 847 .
- Hope , J. and Pothuri , B. ( 2013 ). The role of palliative surgery in gynecologic cancer cases . Oncologist 18 : 73 – 79 .
- Höckel , M. , Horn , L. , and Einenkel , J. ( 2012 ). (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy . Gynecol. Oncol. 127 : 297 – 302 .
- Kaur , M. , Joniau , S. , D'Hoore , A. , and Vergote , I. ( 2014 ). Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy . Curr. Opin. Oncol. 26 : 514 – 520 .
- Forner , M. and Lampe , B. ( 2011 ). Exenteration as a primary treatment for locally advanced cervical cancer: longterm results and prognostic factors . Am. J. Obstet. Gynecol. 205 ( 148 ): e1 – e6 .
- Schmidt , A.M. , Imesch , P. , Fink , D. , and Egger , H. ( 2012 ). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer . Gynecol. Oncol. 125 : 604 – 609 .
- Chiantera , V. , Rossi , M. , De Iaco , P. et al. ( 2014 ). Survival after curative pelvic exenteration for primary or recurrent cervical cancer a retrospective multicentric study of 167 patients . Int. J. Gynecol. Cancer 24 : 916 – 922 .
- Lakhman , Y. , Nougaret , S. , Miccò , M. et al. ( 2015 ). Role of MR imaging and FDG PET/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies . Radiographics 35 : 1295 – 1313 .
-
Chew , M.
,
Yeh , Y.
,
Toh , E.
et al. (
2017
).
Critical evaluation of contemporary management in a new pelvic exenteration unit: the first 25 consecutive cases
.
World J. Gastrointest. Oncol.
15
:
218
–
227
.
10.4251/wjgo.v9.i5.218 Google Scholar
- Baiocchi , G. , Guimaraes , G. , Oliveira , R. et al. ( 2012 ). Prognostic factors in pelvic exenteration for gynecological malignancies . Eur. J. Surg. Oncol. 38 : 948 – 954 .
- Huang , M. , Iglesias , D. , Westin , S. et al. ( 2014 ). Pelvic exenteration: impact of age on surgical and oncologic outcomes . Gynecol. Oncol. 132 : 114 – 118 .
- Iglesias , D. , Westin , S. , Rallapalli , V. et al. ( 2012 ). The effect of body mass index on surgical outcomes and survival following pelvic exenteration . Gynecol. Oncol. 125 : 336 – 342 .
- Tobert , C. , Hamilton-Reeves , J. , Norian , L. et al. ( 2017 ). Emerging impact of malnutrition on surgical patients: literature review and potential implications for cystectomy in bladder cancer . J. Urol. 198 : 511 – 519 .
- Martinez , A. , Filleron , T. , Rouanet , P. et al. ( 2018 ). Prospective assessment of first-year quality of life after pelvic exenteration for gynecologic malignancy: a French multicentric study . Ann. Surg. Oncol. 25 : 535 – 541 .
- Choy , I. , Badgery-Parker , T. , Masya , L. et al. ( 2017 ). Baseline quality of life predicts pelvic exenteration outcome . ANZ J. Surg. 87 : 935 – 939 .
- Marnitz , S. , Köhler , C. , Müller , M. et al. ( 2006 ). Indications for primary and secondary exenterations in patients with cervical cancer . Gynecol. Oncol. 103 : 1023 – 1030 .
- Burger , I. , Vargas , H. , Donati , O. et al. ( 2013 ). The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration . Gynecol. Oncol. 129 : 586 – 592 .
-
Meads , C.
,
Davenport , C.
,
Małysiak , S.
et al. (
2014
).
Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation
.
Br. J. Obstet. Gynecol.
121
:
389
–
407
.
10.1111/1471-0528.12488 Google Scholar
- Sardain , H. , Lavoue , V. , Redpath , M. et al. ( 2015 ). Curative pelvic exenteration for recurrent cervicalcarcinoma in the era of concurrent chemotherapy and radiation therapy . Eur. J. Surg. Oncol. 41 : 975 – 985 .
- Liedberg , F. , Gudjonsson , S. , Xu , A. et al. ( 2017a ). Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch . BJU Int. 120 : 530 – 536 .
- Liedberg , F. , Ahlgren , G. , Baseckas , G. et al. ( 2017b ). Long-term functional outcomes after radical cystectomy with ileal bladder substitute: does the definition of continence matter? Scand. J. Urol. 51 : 44 – 49 .
- Liedberg , F. , Holmberg , E. , Holmäng , S. et al. ( 2012 ). Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey . Scand. J. Urol. Nephrol. 46 : 14 – 18 .
-
Anderson , C.
,
Cookson , M.
,
Chang , S.
et al. (
2012
).
Voiding function in women with orthotopic neobladder urinary diversion
.
J. Urol.
88
:
200
–
204
.
10.1016/j.juro.2012.03.004 Google Scholar
- Bartsch , G. , Daneshmand , S. , Skinner , E.C. et al. ( 2014 ). Urinary functional outcomes in female neobladder patients . World J. Urol. 32 : 221 – 228 .
- Gross , T. , Meierhans Ruf , S. , Meissner , C. et al. ( 2015 ). Orthotopic ileal bladder substitution in women: factors influencing urinary incontinence and hypercontinence . Eur. Urol. 68 : 664 – 671 .
- Eisenberg , M. , Dorin , R. , Bartsch , G. et al. ( 2010 ). Early complications of cystectomy after high dose pelvic radiation . J. Urol. 184 : 2264 – 2269 .
- Meijer , R. , Mertens , L. , Meinhardt , W. et al. ( 2015 ). The colon shuffle: a modified urinary diversion . Eur. J. Surg. Oncol. 41 : 1264 – 1268 .
- Stolzenburg , J. , Schwalenberg , T. , Liatsikos , E. et al. ( 2007 ). Colon pouch (Mainz III) for continent urinary diversion . BJU Int. 99 : 1473 – 1477 .
- Van , Hemelrijck , M. , Thorstenson , A. , Smith , P. et al. ( 2013 ). Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients . BJU Int. 112 : 1113 – 1120 .
- Gan , J. and Hamid , R. ( 2017 ). Literature review: double-barrelled wet colostomy (one stoma) versus Ileal conduit with colostomy (two stomas) . Urol. Int. 98 : 249 – 254 .
- Angioli , R. , Benedetti Panici , P. , Mirhashemi , R. et al. ( 2003 ). Continent urinary diversion and low colorectal anastomosis after pelvic exenteration. Quality of life and complication risk . Crit. Rev. Oncol. Hematol. 48 : 281 – 285 .
- Husain , A. , Akhurst , T. , Larson , S. et al. ( 2007 ). A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration . Gynecol. Oncol. 106 : 177 – 180 .
- Berek , J. , Howe , C. , Lagasse , L. , and Hacker , N. ( 2005 ). Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA . Gynecol. Oncol. 99 : 153 – 159 .
- Soper , J. , Havrilesky , L. , Secord , A. et al. ( 2005 ). Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery . Int. J. Gynecol. Cancer 15 : 542 – 548 .
- Qiu , S. , Jurado , M. , and Hontanilla , B. ( 2013 ). Comparison of TRAM versus DIEP flap in total vaginal reconstruction after pelvic exenteration . Plast. Reconstr. Surg. 132 : 1020 – 1026 .
- Ferrari , J. , Hemphill , A. , and de Jesus , R. ( 2013 ). Modified rotational bowel vaginoplasty after total pelvic exenteration . Ann. Plast. Surg. 70 : 335 – 336 .
- Bridoux , V. , Kianifard , B. , Michot , F. et al. ( 2010 ). Transposed right colon segment for vaginal reconstruction after pelvic exenteration . Eur. J. Surg. Oncol. 36 : 1080 – 1084 .
- Sinna , R. , Alharbi , M. , Assaf , N. et al. ( 2013 ). Management of the perineal wound after abdominoperineal resection . J. Visc. Surg. 150 : 9 – 18 .
- Campbell , C. and Butler , C. ( 2011 ). Use of adjuvant techniques improves surgical outcomes of complex vertical rectus abdominis myocutaneous flap reconstructions of pelvic cancer defects . Plast. Reconstr. Surg. 128 : 447 – 458 .
- Creagh , T. , Dixon , L. , and Frizelle , F. ( 2012 ). Reconstruction with vertical rectus abdominus myocutaneous flap in advanced pelvic malignancy . J. Plast. Reconstr. Aesthet. Surg. 65 : 791 – 797 .
- Fleisch , M. , Pantke , P. , Beckmann , M. et al. ( 2007 ). Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers . J. Surg. Oncol. 95 : 476 – 484 .
- Maggioni , A. , Roviglioni , G. , Landoni , F. et al. ( 2009 ). Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan . Gynecol. Oncol. 114 : 64 – 68 .
- Fotopoulou , C. , Neumann , U. , Kraetschell , R. et al. ( 2010 ). Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies . J. Surg. Oncol. 101 : 507 – 512 .
- Khoury-Collado , F. , Einstein , M. , Bochner , B. et al. ( 2012 ). Pelvic exenteration with curative intent for recurrent uterine malignancies . Gynecol. Oncol. 124 : 42 – 47 .
- Yoo , H. , Lim , M. , Seo , S. et al. ( 2012 ). Pelvic exenteration for recurrent cervical cancer: ten year experience at National Cancer Center in Korea . J. Gynecol. Oncol. 23 : 242 – 250 .
- Chiantera , V. , Rossi , M. , De , Iaco , P. et al. ( 2014 ). Morbidity after pelvic exenteration for gynecological malignancies a retrospective multicentric study of 230 patients . Int. J. Gynecol. Cancer 24 : 156 – 164 .
- Chiantera , V. , Rossi , M. , De , Iaco , P. et al. ( 2014 ). Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients . Int. J. Gynecol. Cancer 24 : 880 – 884 .
- Westin , S. , Rallapalli , V. , Fellman , B. et al. ( 2014 ; 134 ). Overall survival after pelvic exenteration for gynecologic malignancy . Gynecol. Oncol. : 546 – 551 .
- Shimko , M. , Tollefson , M. , Umbreit , E. et al. ( 2011 ). Long-term complications of conduit urinary diversion . J. Urol. 185 : 562 – 567 .
- Ang , C. , Bryant , A. , Barton , D.P.J. et al. ( 2014 ). Exenterative surgery for recurrent gynaecological malignancies . Cochrane Database Syst. Rev. (( 2 ): CD010449.
- Arians , N. , Foerster , R. , Rom , J. et al. ( 2016 ). Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT) . Radiat. Oncol. 11 : 44 .
- Graves , S. , Seagle , B. , Strohl , A. et al. ( 2017 ). Survival after pelvic exenteration for cervical cancer: a National Cancer Database study . Int. J. Gynecol. Cancer 27 : 390 – 395 .
- PelvExCollaborative ( 2019 ). Pelvic exenteration for advanced nonrectal pelvic malignancy . Ann. Surg. 270 : 899 – 905 .
- Benn , T. , Brooks , R. , Zhang , Q. et al. ( 2011 ). Pelvic exenteration in gynecologic oncology: a single institution study over 20 years . Gynecol. Oncol. 122 : 14 – 18 .
- Armbruster , S. , Sun , C. , Westin , S. et al. ( 2018 ). Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration . Gynecol. Oncol. 149 : 484 – 490 .